featured
Risk of Ocular Neovascular Conversion and Systemic Bleeding Complications in Patients With AMD on DOACs or Warfarin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of ocular neovascular conversion and systemic bleeding complications in patients with AMD on DOACs or Warfarin
Ophthalmology 2024 Aug 06;[EPub Ahead of Print], AF Alsoudi, E Koo, K Wai, P Mruthyunjaya, E RahimyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.